Objectives. The bsa locus of Burkholderia pseudomallei encodes several proteins that are components of the type III secretion system (TTSS). BipC was postulated as one of the TTSS-3 effector proteins, but its role in the pathogenesis of B. pseudomallei infection is not well understood. Thus, the aim of this study was to determine its role(s) in the virulence of B. pseudomallei pathogenesis.
Burkholderia pseudomallei is an infectious gramnegative motile bacillus. B. pseudomallei causes melioidosis, a fatal disease that affects humans and animals, and is endemic in southeast Asia, especially northeast Thailand, and in northern Australia [1] [2] [3] . In 2002, B. pseudomallei was classified as a category B biothreat agent by the Centers for Disease Control and Prevention because of its capability to establish a life-threatening infection that can be transmitted via the aerosol route, as well as its intrinsic resistance to a large number of currently available antimicrobial agents [4] . Eradication of B. pseudomallei infection has proven difficult because this tiny bacillus is able to persist indefinitely within the host, with a high incidence of relapse, despite prolonged and appropriate antibiotic treatment [5] .
B. pseudomallei possesses several virulence determinants that allow the pathogen to invade the host cells. Of particular interest is the type III secretion system (TTSS), which has been demonstrated to be used by numerous gram-negative pathogens to deliver virulence factors directly into the cytoplasm of the host cell [6] . Recently, the number of studies focusing on the secretion system of B. pseudomallei has increased tremendously [7] [8] [9] . The B. pseudomallei genome harbors 3 TTSSs, but only the third cluster, TTSS-3, also known as the bsa locus, has been shown to be involved in mammalian cell infection and to be essential for the maximal virulence of this pathogen [9, 10] . Within the B. pseudomallei bsa locus, the translocator proteins were shown to interact with the eukaryotic cell membrane and mediate the delivery of secreted effector proteins that inhibit the cellular processes of the host cell [11] .
The Burkholderia invasion proteins (Bip proteins), which include BipB, BipC, and BipD of the Bsa TTSS, have previously been identified as protein translocators [12] . Mutations in both bipB and bipD were shown to have pleiotropic effects that prevented the delivery of the effector proteins into the host cell. According to Steven et al [13] , inactivation of bipD significantly impaired bacterial intracellular replication in murine macrophage-like cells. In another mutational study conducted by Suparak et al [14] , the bipB mutant demonstrated reduced efficiency in multinucleated giant cell formation, cellto-cell spreading, and induction of apoptotic death in infected macrophages. Inactivation studies of bipB and bipD provided initial evidence for the importance of the proteins they encode in the B. pseudomallei entry mechanism. To date, no experimental data are available on the role(s) of BipC in B. pseudomallei pathogenesis.
A recent study by our group demonstrated the presence of BipC in the secretome of B. pseudomallei on laboratory culture, and BipC was found to be immunogenic as demonstrated by reactivity to mouse anti-B. pseudomallei sera [15] . However, the role(s) of bipC in the pathogenesis of B. pseudomallei infection remains to be elucidated. BipC displays 30% amino acid sequence identity to Salmonella SipC invasin [16] . In Salmonella TTSS, SipC is one of the translocator proteins that integrates into the host cell membrane, resulting in actin condensation and cytoskeletal rearrangements that facilitate the formation of bacterial entry foci [17] . Thus, we postulate that BipC might play a similar role in B. pseudomallei pathogenesis. In this study, we investigated the functional roles of bipC in B. pseudomallei virulence through a mutagenesis approach.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture Conditions B. pseudomallei K96243 was cultured and maintained in LuriaBertani (LB) agar (Difco, Detroit, Michigan) broth. All plasmids were propagated in Escherichia coli Top10. E. coli S17-1/ λpir, which has chromosomally integrated conjugal transfer functions, was used for transformation and conjugation experiments. All bacterial strains used in mutant construction were grown at 37°C on LB agar containing appropriate antibiotics, unless otherwise specified (Supplementary Table 1 ).
Construction of B. pseudomallei bipC Mutant, BM16, and Complementation Strain B. pseudomallei K96243 genomic DNA was extracted from B. pseudomallei overnight culture, using a Wizard genomic DNA purification kit (Promega, Madison, Wisconsin) according to the manufacturer's instructions. The bipC mutant and complemented strains were constructed to determine the functions of this gene in B. pseudomallei. Details of the method are provided in the Supplementary Materials.
Adherence and Invasion Assays
The human lung epithelial cell line A549 was used to perform the adherence and invasion assays as described previously [18] Missouri) , to eliminate the residual extracellular bacteria. After 2 hours, the viable intracellular bacteria were released from the infected cells by lysis with 0.1% (v/v) Triton X-100 and plated onto nutrient agar (NA) for 24 hours at 37°C. The uninfected cells were used as negative control. All assays were conducted in triplicate and repeated 3 times.
Intracellular Survival Assay
The intracellular survival assay was conducted as previously described [19] . In brief, the A549 cells were infected with bacteria at a multiplicity of infection (MOI) of 10:1 as described in the adherence and invasion assays above. Thereafter, the cells were replenished with fresh culture medium containing 50 µg/ mL of kanamycin and incubated for an additional 2, 4, 6, and 8 hours. The monolayers were then lysed using 0.1% (v/v) Triton X-100 to release the intracellular bacteria, and serially diluted cell lysates were plated on NA for 24 hours at 37°C. The uninfected cells were used as negative control in this assay. This assay was performed in triplicate and repeated 3 times.
Actin Filaments Detection Assay
To investigate whether BipC nucleates actin filament formation in vitro, immunofluorescence staining of B. pseudomalleiinfected cell lines was performed as described by Sitthidet et al [20] with slight modifications. In brief, 5 × 10 5 A549 cells were grown overnight on 13-mm glass coverslips (Corning Glass Works, Corning, New York) and infected with B. pseudomallei strains at the MOI of 10:1 as described above from the adherence and invasion assays. Subsequently, at 6 and 10 hours after infection, cells were fixed overnight with 4% freshly prepared paraformaldehyde, permeabilized with 0.1% (v/v) Triton X-100 for 15 minutes, and blocked with 1% (w/v) bovine serum albumin for 30 minutes. The permeabilized infected cells were incubated for 1 hour with anti-B. pseudomallei lipopolysaccharide mouse immunoglobulin G (IgG; Santa Cruz Biotechnology, Santa Cruz, California), followed by staining for the intracellular B. pseudomallei, using fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG polyvalent IgG for 1 hour. The actin fibers were then stained using rhodamine-conjugated phalloidin (Molecular Probes, Eugene, Oregon) for 15 minutes, and the nuclei of eukaryotic cells were finally mounted with SlowFade Gold Antifade reagent containing 4′,6′ diamidine-2′-phenylindole dihydrochloride (Invitrogen, Carlsbad, California). The stained cells were observed with Axio Imager.Z2 with ApoTome.2 (Carl Zeiss, Goettingen, Germany), and the images were analyzed with Zen software. The 63× objective under oil immersion was used for all data sets. Five fields from each of the coverslips were examined for the intracellular bacteria. Uninfected A549 cells were used as negative control.
Phagosomal Escape Assay
The capacity of bacteria to escape from phagosomes was evaluated using the modified chloroquine resistance test for Shigella [21] . Briefly, 5 × 10 5 U937 cells were seeded with 5 ng/mL of phorbol 12-myristate 13-acetate (Sigma, St. Louis, Missouri), followed by incubation at 37°C with 5% CO 2 for 48 hours. Confluent cell monolayers were washed and infected at a MOI of 10:1. After 30 minutes of incubation, cells were washed with PBS and further incubated with fresh medium containing 250 µg/mL of kanamycin with or without 2.5 mg/mL chloroquine for 1 hour at 37°C. Cells were washed and lysed in 0.1% (v/v) Triton X-100. Dilutions of cell lysates were plated on NA, and CFU were counted after incubation for 24 hours at 37°C. The untreated cells served as a negative control. The assay was done in triplicate and repeated 3 times.
Cell Viability Assay
The colorimetric MTT metabolic activity assay was performed to determine the B. pseudomallei WT-and mutant strainmediated cytotoxicity against U937 cells [19] . In this study, U937 cells were infected with B. pseudomallei strains at a MOI of 10:1, following by incubation for 2 and 24 hours in RPMI 1640 medium containing 250 µg/mL of kanamycin. The MTT assay was performed according to the manufacturer's instructions (Sigma, St. Louis, Missouri). Briefly, 10 µL of 5 mg/mL MTT solution in PBS was added after the supernatant was removed, and incubation was performed at 37°C for 4 hours. The medium with MTT solution was removed, and 100 µL of dimethyl sulfoxide (Univar, Ingleburn, Australia) was added to solubilize the formazan crystals formed in viable cells. The plates were then transferred to a microtiter plate reader (BioRad, Philadelphia, Pennsylvania), and absorbance was measured at OD 570 nm . Cells treated with RPMI 1640 medium only served as a negative control. The experiment was performed 3 times in triplicate.
Mice Infection Study with B. pseudomallei
Six-week-old pathogen-free female BALB/c mice were housed in high-temperature polysulfone (Techniplast, Exton, Pennsylvania) cages with a bedding of paper shavings, subjected to a 12-hour light/dark cycle, and fed a diet of commercial pellets, with water provided ad libitum. , and the animal experiments were performed in accordance with the University Malaya animal ethics guidelines. The virulence of the bipC mutant strain in a BALB/c mouse model of melioidosis was assayed as previously described by Stevens et al [13] . In brief, groups of 5 BALB/c mice were each inoculated intraperitoneally with approximately 1 × 10 6 CFU/mL of B. pseudomallei WT, BM16, or BM16/pUCP28T-bipC. Another 5 mice were injected with 200 µL of sterile PBS to serve as the control group. The mice were monitored twice daily for signs of infection and death throughout the test duration of 35 days [22, 23] .
Statistical Analysis
Statistical analysis of differences between the experimental groups was performed using 1-way analysis of variance, available in SPSS software. The data are presented as mean values ± standard errors of the mean. A P value of < .05 was considered statistically significant.
RESULTS

BipC Enhancement of Host Cell Adhesion and Invasion
The B. pseudomallei bipC mutant was constructed by insertional mutagenesis to investigate its importance in the pathogenesis of melioidosis. Polymerase chain reaction (PCR) analysis confirmed insertion of the recombinant suicide vector at the desired location (data not shown). Reverse-transcription PCR analysis demonstrated that expression of the downstream bprA and bipD genes was not affected (Supplementary Figure 1) , thus indicating that the deletion in bipC did not confer any polar effect to the downstream genes. To elucidate whether BipC mounts an essential role in the initial infectious process, BM16 was assayed for its ability to adhere to and invade A549 cells. BM16 exhibited a statistically significant reduction (P < .01) in cell adherence efficiency, compared with WT ( Figure 1A) . Similarly, the number of internalized BM16 substantially decreased (Figure 1B) . Complementation of BM16 restored both adhesion and invasion levels, which indicated that changes in host cell attachment and invasion were due to the mutation in bipC, BM16. As expected, the presence of empty vector in BM16 did not affect the recovery of adherent or intracellular bacteria. Taken together, our observations demonstrate that BipC may promote a role in bacterial attachment and invasion to A549 pneumocytes.
bipC Mutant Exhibited Delay in Intracellular Growth
A modified kanamycin protection assay was conducted to determine intracellular replication of B. pseudomallei WT and BM16 within A549 pneumocytes. The bacterial CFU of WT and complemented strains were increased 6 hours after infection, whereas the CFU of BM16, with or without the empty shuttle vector, was increased 8 hours after infection (Figure 2 ). At the 8-hour time point, 2.21 ± 0.12 × 10 5 CFU/mL of intracellular WT bacteria were recovered, compared with 3.09 ± 0.27 × 10 4 CFU/mL of bacteria recovered 2 hours after infection, establishing a 7-fold increase in the bacterial numbers. In contrast, there was only a 3-fold increase in bacterial count when BM16 was used. The defective growth phenotype was restored by the complemented strain, in which nearly a 9-fold increase in bacterial number was observed 8 hours after infection. These results show that BipC may be required for efficient intracellular proliferation of B. pseudomallei within A549 cells.
bipC Exhibit Delay in the Actin-Based Motility Formation
Microscopy analysis was performed to assess the ability of BM16 to induce actin tail formation. Six hours after infection, there was no intense filamentous actin staining observed in the BM16-infected cells, compared with WT-and BM16/pUCP28T-bipCinfected A549 cells. These micrographs showed that actin-based motility was evident in the cells infected with WT and complemented strains but not in cells infected with BM16 ( Figure 3A , 3C, and 3E). However, 10 hours after infection, actin polymerization was apparent in BM16-infected cells ( Figure 3D ). This finding indicates that BM16 exhibits delay in intracellular and intercellular spread via actin-based motility and the peripheral membrane protrusions formed in the cells.
BipC May Facilitate Phagosomal Escape
The ability of BM16 to escape from phagocytic vacuoles was evaluated through the chloroquine resistance assay. In this assay, chloroquine accumulates in phagosomes and kills the bacteria that do not escape into cytoplasm. Therefore, similar colony counts recovered from infected cultures treated with or without chloroquine indicate phagosomal escape, while the lower counts indicate bacterial phagosomal localization. BM16 was significantly impaired in its ability to escape the phagosomes, as reflected by the drastic 2-fold reduction in the number of intracellular bacteria recovered from infected macrophages in the presence of chloroquine, compared with WT (38.91% ± 4.53% vs 74.17% ± 1.99%; P < .01; Figure 4 ). Complementation of BM16 restored the parental phenotype (71.35% ± 6.44%). Together, these results indicate that BipC may play a pivotal role in facilitating phagosomal escape in cells.
BipC Is Required for Efficient In Vitro Cytotoxicity
The MTT assay was performed to quantitate macrophagemediated cytotoxicity following infection with B. pseudomallei at different time points after infection. For all strains tested, the U937 cells remained >90% viable 2 hours after infection. Twenty-four hours after infection, the viability of BM16-infected cells was significantly greater than that of cells infected with WT (67.93% ± 4.67% vs 41.32% ± 3.92%). Exposure of the WT strain to the U937 cells demonstrated that 92.43% ± 0.71% of cells had survived at 2 hours. From 2 to 24 hours after infection, the percentage of cells that survived decreased gradually. A similar pattern of cell survival was observed when the U937 cells were infected with the BM16/pUCP28T-bipC strain, whereby the cell survival decreased between 2 and 24 hours. Figure 4 . Phagocytosis assay. Lysis of the phagocytic vacuole by Burkholderia pseudomallei K96243 (wild type), BM16 (bipC::pKCm bipC ), BM16/pUCP28T-bipC (BM16 harboring pU bipC ), and BM16/pUCP28T (BM16 harboring pUCP28T). The ability of the bipC mutant to escape from the phagosome in infected macrophages was expressed relative to that of the wild-type strain K96243. The percentage of bacteria that escaped from phagosomes was calculated as follows: [CFU recovered from cells treated with both kanamycin and chloroquine/CFU recovered from cells treated with kanamycin only] × 100%, where "CFU" denotes colony-forming units. Asterisks indicate significant differences (**P < .01) between wild type and BM16 (P = .005), wild type and BM16/pUCP28T (P = .008), BM16/pUCP28T-bipC, and BM16 (P = .008) and between BM16/pUCP28T-bipC and BM16/pUCP28T (P = .013). Values indicate the means ± standard error of the mean of 3 independent experiments assayed in triplicate. , BM16/pUCP28T-bipC (E and F ), and control (G) at a multiplicity of infection of 10 were examined at 6 hours (A, C, and E ) and 10 hours (B, D, and F ) after infection. Bacteria were stained green with anti-B. pseudomallei lipopolysaccharide mouse immunoglobulin G (IgG) and fluorescein isothiocyanate-conjugated anti-mouse IgG polyvalent IgG, actin fibers (white arrow) were stained red with rhodamine-conjugated phalloidin, and nuclei were stained blue with 4′,6′diami-dine-2′-phenylindole dihydrochloride. The micrographs are representative of at least 3 independent experiments.
Subsequently, only 42.10% ± 2.63% of cells survived after 24 hours of infection. The survival rate of the U937 cells infected with the BM16 and BM16/pUCP28T strains were comparatively higher (approximately 25%-30%) than that for cells infected with the WT and BM16/pUCP28T-bipC strains ( Figure 5 ).
bipC Mutation Impaired B. pseudomallei Virulence in Murine Infection Model
The BALB/c mice were infected intraperitoneally with B. pseudomallei WT, BM16, and BM16/pUCP28T-bipC strains to determine the virulence level of the bipC mutant. All mice succumbed to infection within 2 days after inoculation with the WT and BM16/pUCP28T-bipC strains. The mice demonstrated lethargy, and all died within 1-2 days. In contrast, mice infected with BM16 were less sick and survived throughout the test duration ( Figure 6 ). This finding indicates that BipC is required for B. pseudomallei virulence in this murine model of melioidosis.
DISCUSSION
The role of BipC in regulating bacterial virulence is of considerable interest in this study as it has been shown earlier that
SipC from Salmonella and IpaC from Shigella play important roles in the function of the type III secretion system [17, 24, 25] . In this study, the B. pseudomallei bipC mutant was instrumental in providing initial evidence for the crucial role of this protein in invasion and infection. In general, the principal function of a secreted effector is to induce membrane ruffling, leading to the formation of an entry focus that mediates bacterial uptake into host epithelial cells [26] [27] [28] [29] . The reduced efficiency in the ability of the bipC mutant to adhere to and invade human cells suggests that the deletion of this gene may have resulted in the less adhesive and invasive phenotype with a secretion defect of this protein. Watarai et al [30] reported that the BipC homologous protein in Shigella species, IpaC, can bind the receptor α 5 β 1 integrin and stimulate the phosphorylation of a focal adhesion kinase. Thus, it is possible that BipC initiates attachment and invades the host cell membrane. Besides the decrease in invasion of the bipC mutant, this study suggests that BipC might be involved in actin bundling and nucleation, as is the case for some of the pathogens, such as Yersinia, Salmonella, and Shigella species, that seem to have exploited their interactions with host-cell receptors, not only to adhere but also to trigger actin cytoskeleton rearrangements that can lead to cellular invasion [29, 31, 32] . Microscopy analysis demonstrated delay for actin formation in the mutant as compared to the WT. This may indicate that BipC is capable of delayed escape from the endosomal vacuoles and able to spread intracellularly and intercellularly via actin-based motility upon entry into the cytoplasm. In this context, emerging evidence indicated that intracellular and intercellular spread via actin-based motility facilitates cell-to-cell fusion [33] . In Shigella species, spreading depends on the efficiency of bacterial invasion into the epithelial cytosol, formation of protrusion, and lysis of the double-membrane vacuole to release bacteria into 6 colony-forming units of Burkholderia pseudomallei K96243 (wild type), BM16, and BM16/pUCP28T-bipC. Mice were observed twice daily, and the percentage of survival was plotted against time.
the adjacent cell [34] . However, the mechanism of actin-based motility for Burkholderia species may differ from that for Shigella species or other intracellular pathogens, such as Listeria species [35] .
Critically, one of the possible factors that might be associated with the virulence of B. pseudomallei is the exit strategies used by this intracellular pathogen in the infectious cycle. Following the entry process, some intracellular pathogens escape from their resident phagosome into the cytoplasm to successfully grow and replicate [36] . Studies on other Bips showed that these proteins are required for bacterial escape from vacuoles of the infected cells [14, 37] . With respect to this phagosomal escape into the cytoplasm of the host cell, the lesser efficiency of escape demonstrated by the bipC mutant implies that BipC may participate in the lysis of the resulting phagosomal membrane and escape into the host cell cytoplasm. The absence of phagosomal escape of the mutant strain may be a contributing factor to the incapability of the strain to survive and effectively replicate intracellularly [14, 17] .
The cytotoxicity of BipC in vitro was quantitatively evaluated, and it was clearly shown that mutation in bipC is significantly less cytotoxic against macrophages. The lesser cytotoxicity toward macrophages was predicted to influence the ability of these cells to act as antigen-presenting cells that activate adaptive immunity against B. pseudomallei infections and, thus, subvert the host immune system [37, 38] . Druar et al [39] reported that BipB, BipC, or BipD were not protective antigens and suggested that these TTSS3 components were primarily used for intracellular parasitism. Infection with Salmonella SipC was reported to result in mucosal inflammation in response to macrophage cytotoxicity. Cytotoxicity of this pathogen is manifested by inhibition of membrane ruffling and macropinocytosis, finally causing cell death in the infected macrophages [40] . In this respect, BipC may be acting in an analogous manner to the Salmonella SipC protein, which induced death for the infected cells. However, this remains to be elucidated.
To gain further insight into the importance of BipC in B. pseudomallei pathogenesis, an in vivo infection experiment using BALB/c mice was conducted. We demonstrated a significantly longer life span of the mice infected with the bipC mutant, compared with WT. Such attenuated virulence may be attributed to the reduced bacterial capacity in host cell invasion and cell-tocell spreading, as well as to increased bacterial susceptibility to the host immune cells [41] . This finding is also in agreement to that of Suparak et al [14] , in which the bipB mutant exhibited lower virulence as compared to WT in the pulmonary model of melioidosis in BALB/c mice. Thus, BipC directly or indirectly plays a critical role in the virulence of B. pseudomallei.
Collectively, it is clear that the type III secretion effectors, including BipC, act as bona fide virulence factors in B. pseudomallei pathogenesis. This finding implies that a thorough understanding of the function of BipC will provide important insights into the unique intracellular life cycle of B. pseudomallei. Nevertheless, there are still many other questions that remain to be answered. In particular, it is important to identify host cell proteins interacting with BipC to further dissect the molecular role of BipC in the infection process. This would provide deeper insight into the enigmatic mechanisms by which B. pseudomallei may modulate the host immune system and establish persistent infection.
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